References
- Ferro C J, Webb D J. Endothelial dysfunction and hypertension. Drugs 1997; 53(suppl 1)30–41, [PUBMED], [INFOTRIEVE]
- Roberts J M, Taylor R N, Musci T J, Rodgers G M, Hubel C A, McLaughlin M K. Preeclampsia: an endothelial cell disorder. Am J Obstet Gynecol 1989; 161: 1200–1204, [PUBMED], [INFOTRIEVE]
- Conrad K P, Benyo D F. Placental cytokines and the pathogenesis of preeclampsia. Am J Reprod Immunol 1997; 37: 240–249, [PUBMED], [INFOTRIEVE], [CSA]
- Deng L, Bremme K, Hansson L O, Blombäck M. Plasma levels of von Willebrand factor and fibronectin as markers of persisting endothelial damage in preeclampsia. Obstet Gynecol 1994; 84: 941–945, [PUBMED], [INFOTRIEVE], [CSA]
- Redman C WG, Sacks G P, Sargent I L. Preeclampsia: an excessive maternal inflammatory response to pregnancy. Am J Obstet Gynecol 1999; 180: 499–506, [PUBMED], [INFOTRIEVE], [CSA]
- Naccasha N, Gervasi M‐T, Chaiworapongsa T, Berman S, Yoon B H, Maymon E, Romero R. Phenotypic and metabolic characteristics of monocytes and granulocytes in normal pregnancy and maternal infection. Am J Obstet Gynecol 2001; 185: 1118–1123, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Sacks G P, Studena K, Sargent I L, Redman C WG. Normal pregnancy and preeclampsia both produce inflammatory changes in peripheral blood leukocytes akin to those of sepsis. Am J Obstet Gynecol 1998; 179: 80–86, [PUBMED], [INFOTRIEVE], [CSA]
- Lurie S, Frenkel E, Tuvbin Y. Comparison of the differential distribution of leukocytes in preeclampsia versus uncomplicated pregnancy. Gynecol Obstet Invest 1998; 45: 229–231, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Gervasi M‐T, Chaiworapongsa T, Pacora P, Naccasha N, Yoon B H, Maymon E, Romero R. Phenotypic and metabolic characteristics of monocytes and granulocytes in preeclampsia. Am J Obstet Gynecol 2001; 185: 792–797, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Von Dadelszen P, Wilkins T, Redman C WG. Maternal peripheral blood leukocytes in normal and pre‐eclamptic pregnancies. Br J Obstet Gynaecol 1999; 106: 576–581, [PUBMED], [INFOTRIEVE], [CSA]
- Crocker I P, Wellings R P, Fletcher J, Baker P N. Neutrophil function in women with pre‐eclampsia. Br J Obstet Gynaecol 1999; 106: 822–828, [PUBMED], [INFOTRIEVE], [CSA]
- Tracey K J, Cerami A. Tumor necrosis factor: a pleiotropic cytokine and therapeutic target. Annu Rev Med 1994; 45: 491–503, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Conrad K P, Miles T M, Benyo D F. Circulating levels of immunoreactive cytokines in women with preeclampsia. Am J Reprod Immunol 1998; 40: 102–111, [PUBMED], [INFOTRIEVE], [CSA]
- Visser W, Beckmann I, Bremer H A, Han L L, Wallenburg H CS. Bioactive tumour necrosis factor‐α in pre‐eclamptic patients with and without the HELPP syndrome. Br J Obstet Gynaecol 1994; 101: 1081–1082, [PUBMED], [INFOTRIEVE], [CSA]
- Kupferminc M J, Peacemen A M, Aderka D, Wallach D, Socol M L. Soluble tumor necrosis factor receptors and interleukin‐6 levels in patients with severe preeclampsia. Obstet Gynecol 1996; 88: 420–427, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Chen G, Wilson R, Wang S H, Zheng H Z, Walker J J, McKillop J H. Tumor necrosis factor alpha (TNF‐α) gene polymorphism and expression in pre‐eclampsia. Clin Exp Immunol 1996; 104: 154–159, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Visser W, Beckmann I, Knook M AH, Wallenburg H CS. Soluble necrosis factor receptor II and soluble cell adhesion molecule‐I as markers of tumor necrosis factor‐α release in preeclampsia. Acta Obstet Gynecol Scand 2002; 81: 713–719, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Saito S, Umekage H, Sakamoto Y, Sakai M, Tanebe K, Sasaki Y, Morikawa H. Increased T‐Helper‐1‐type immunity and decreased T‐Helper‐2‐type immunity in patients with preeclampsia. Am J Reprod Immunol 1999; 41: 297–306, [PUBMED], [INFOTRIEVE], [CSA]
- Orange S, Horvath J, Hennessy A. Preeclampsia is associated with a reduced interleukin‐10 production from peripheral blood mononuclear cells. Hypertens Pregnancy 2003; 22: 1–8, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Beckmann I, Ben‐Efraim S, Vervoort M, Wallenburg H CS. Release of tumor necrosis factor‐α and prostanoids in whole blood cultures after in vivo exposure to low‐dose aspirin. Mediators Inflamm 2001; 10: 81–88, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Martin J.N., Jr., Rinehart B K, May W L, Magann E F, Terrone D A, Blake P G. The spectrum of severe preeclampsia: comparative analysis by HELLP (hemolysis, elevated liver enzyme levels, and low platelet count) syndrome classification. Am J Obstet Gynecol 1999; 180: 1373–1384, [PUBMED], [INFOTRIEVE], [CSA]
- Efrati P, Presentey B, Margalith M, Rozenszajn L. Leukocytes of normal pregnant women. Obstet Gynecol 1964; 23: 429–432, [PUBMED], [INFOTRIEVE]
- Letsky E A. The haematological system. Clinical Physiology in Obstetrics, G F Chamberlain, F Broughton Pipkin. Blackwell Science, Oxford 1998; 71–110
- Terrone D A, Rinehart B K, May W L, Moore A, Magann E F, Martin J.N., Jr. Leukocytosis is proportional to HELLP syndrome severity: evidence for an inflammatory form of preeclampsia. South Med J 2000; 93: 768–771, [PUBMED], [INFOTRIEVE], [CSA]
- De Groote D, Zangerle P F, Gevaert Y, Fassotte M F, Beguin Y, Noizat‐Pirenne F, Pirenne J, Gathy R, Lopez M, Dehart I. Direct stimulation of cytokines IL‐1 beta, TNF‐alpha, IL‐6, IL‐2, IFN‐gamma, and GM‐CSF in whole blood. I. Comparison with isolated PBMC stimulation. Cytokine 1992; 4: 239–248, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Entzian P, Linnemann K, Schlaak M, Zabel P. Obstructive sleep apnea syndrome and circadian rhythms of hormones and cytokines. Am J Respir Crit Care Med 1996; 153: 1080–1086, [PUBMED], [INFOTRIEVE], [CSA]
- Marzi M, Vigano A, Trabattoni D, Villa M L, Salvaggio A, Clerici E, Clerici M. Characterization of type 1 and type 2 cytokine production profile in physiologic and pathologic human pregnancy. Clin Exp Immunol 1996; 106: 127–133, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Rein D T, Schöndorf T, Göhring U‐J, Kurbacher C M, Pinto I, Breidenbach M, Mallmann P, Kolhagen H, Engel H. Cytokine expression in peripheral blood lymphocytes indicates a switch to THELPER cells in patients with preeclampsia. J Reprod Immunol 2002; 54: 133–142, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- McHugh S, Deighton J, Rifkin I, Ewan P. Kinetics and functional implications of Th1 and Th2 cytokine production following activation of peripheral blood mononuclear cells in primary culture. Eur J Immunol 1996; 26: 260–1265
- Henderson D C, Rippin J J. Stimulus‐dependent production of cytokines and pterins by peripheral blood mononuclear cells. Immunol Lett 1995; 45: 29–34, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Bellingan G. Inflammatory cell activation in sepsis. Br Med Bull 1999; 55: 12–29, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Louis E, Franchimont D, Piron A, Gevaert Y, Schaaf‐Lafontaine N, Roland S, Mahieu M, Malaise M, De Groote D, Louis R, Belaiche J. Tumour necrosis factor (TNF) gene polymorphism influences TNF‐α production in lipopolysaccharide (LPS)‐stimulated whole blood cell culture in healthy humans. Clin Exp Immunol 1998; 113: 401–406, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Mira J‐P, Cariou A, Grall F, Delclaux C, Losser M‐R, Heshmati F, Cheval C, Monchi M, Teboul J L, Riche F, Leleu G, Arbibe L, Mignon A, Delpech M, Dhainaut J F. Association of TNF2, a TNF‐α promoter polymorphism, with septic shock susceptibility and mortality: a multicenter study. JAMA 1999; 282: 561–568, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Westendorp R G, Langermans J A, Huizinga T W, Elouali A H, Verweij C L, Boomsma D I, Vandenbroucke J P. Genetic influence on cytokine production and fatal meningococcal disease. Lancet 1997; 349: 170–173, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Terranova P F, Hunter V J, Roby K F, Hunt J S. Tumor necrosis factor‐α in the female reproductive tract. Proc Soc Exp Biol Med 1995; 209: 325–342, [PUBMED], [INFOTRIEVE], [CSA]